Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Fluorouracil/epinephrine injectable gel approved

June 7, 1996

SmithKline Beecham's penciclovir available in U.K. market

June 7, 1996

Toyama reveals antiherpes compounds

June 7, 1996

A7-183: Effective topical therapy of recurrent herpes labialis and genitalis

June 7, 1996

Xoma granted U.S. patent for use of BPI

June 7, 1996

Kyowoa Hakko's RP-1551-2: a novel antimicrobial agent

June 7, 1996

Glaxo Wellcome and Otsuka sign grepafloxacin licensing agreement

June 7, 1996

Antiherpes prodrug shows greater activity than aciclovir

May 31, 1996

FDA approves piperacillin sodium/tazobactam sodium for new indication

May 31, 1996

Bayer announces formulation of antibacterial agents

May 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Parabilis takes top spot, pricing largest biopharma IPO at $670M
BioWorld
Less than two months after Kailera Therapeutics Inc. made headlines with biopharma’s largest IPO to date, Parabilis Medicines Inc. has come along and surpassed...